A
$ Value
$0
Shares
15,625
Price
$0
Filed
Mar 6
Insider
Name
HERSHBERG ROBERT
Title
—
CIK
0001274139
Roles
Director
Transaction Details
Transaction Date
2026-03-04
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
62,347
Filing Info
HERSHBERG ROBERT's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | ADPT | A | $0 |
| 2025-12-10 | ADPT | ▼ | $367K |
| 2025-11-05 | ATAI | A | $0 |
| 2025-11-05 | ATAI | A | $0 |
| 2025-11-05 | ATAI | A | $0 |
| 2025-11-05 | ATAI | A | $0 |
| 2025-09-17 | HLVX | U | — |
| 2025-06-18 | RXRX | A | $0 |
| 2025-06-18 | RXRX | A | $0 |
Other Insiders at ADPT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GRIFFIN MICHELLE RENEE | — | $949K | 2026-03-11 |
| NEUPERT PETER M | — | — | 2026-03-04 |
|
ROBINS CHAD M
CEO and Chairman
|
— | $18.6M | 2026-04-08 |
|
LO FRANCIS
Chief People Officer
|
— | $1.3M | 2026-04-08 |
|
PISKEL KYLE
Chief Financial Officer
|
— | $286K | 2026-03-11 |
|
RUBINSTEIN JULIE
President and COO
|
— | $12.3M | 2026-04-21 |
|
ROBINS HARLAN S
Chief Scientific Officer
|
— | $7.5M | 2026-04-08 |
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
|
— | $831K | 2026-03-11 |
|
BOBULSKY SUSAN
Chief Commercial Officer, MRD
|
— | $544K | 2026-03-11 |
| OWEN KATEY EINTERZ | — | — | 2026-03-04 |